STREAMING NOW: Watch Now

Experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds

Sometimes, Ellis Glover would be forced to leave her friends and sit at a lunch table where no one was eatin...

Posted: Nov 28, 2018 2:18 AM
Updated: Nov 28, 2018 2:18 AM

Sometimes, Ellis Glover would be forced to leave her friends and sit at a lunch table where no one was eating peanut butter and jelly sandwiches.

"I wanted to sit with my good, good friends, but I couldn't," the 10-year-old said. "If you're a kid and you have a food allergy, it's harder on you. You're missing out on a lot of stuff other children can have. I always want to try peanut stuff."

Allergies

Business and industry sectors

Business, economy and trade

Children

Children's health

Consumer products

Demographic groups

Diseases and disorders

Families and children

Family members and relatives

Food allergies

Food and drink

Food products

Government organizations - US

Health and health care (by demographic group)

Health and medical

Kinds of foods and beverages

Maternal and child health

Medical fields and specialties

Nuts

Pediatrics

Pharmaceutical industry

Pharmaceuticals

Pharmaceuticals and prescription drugs

Population and demographics

Society

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Experimentation and research

Human subjects

Science

Mom Monica Glover said the family discovered Ellis' peanut allergy when she was about 3. The tipoff: a skin reaction around her mouth after she was given food with a small amount of peanuts in it. "We were lucky to have discovered it that way. That was a mild reaction," Glover said, and a doctor confirmed the allergy through tests.

The discovery was "distressing," Glover said. Accidental exposure to peanuts has happened, resulting in "severe stomach cramps and vomiting," she said. "Essentially, we have to live in fear all the time of Ellis being inadvertently exposed to peanuts and having a reaction that is potentially life-threatening."

Glover seized the opportunity to participate in a study on the safety and effectiveness of an experimental treatment that could give her daughter protection against accidental exposure to peanuts. Despite the risk, it was "a gift," she said, adding that her family hoped their efforts might help "lots of other children."

The risk paid off: Two-thirds of the kids in the study were able to eat the equivalent of two peanuts without any symptoms after following the months-long experimental treatment regimen, the researchers found.

Ellis is one of the majority of children for whom the treatment works. "It's been a huge success," her mother said.

The study results, published Sunday in the New England Journal of Medicine and presented at the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting, prove that the treatment can protect some children against accidental exposure to or ingestion of a very small amount of peanuts or peanut products.

Not a cure

Dr. Brian Vickery, the study's lead author, director of the Children's Healthcare of Atlanta Food Allergy Program and an associate professor of pediatrics at the Emory University School of Medicine, cautioned that "it's not a cure."

"It does not make the allergy to go away," Vickery said. "The purpose is not to get them to be no longer peanut allergic and allow them to eat whatever they want."

Still, that's no small accomplishment, he said. There are no US Food and Drug Administration-approved treatment options for food allergies of any kind or peanut allergy in particular, which, along with tree nut allergy, affects an estimated 3 million Americans or more.

Aimmune Therapeutics Inc., the California-based biopharmaceutical company that made the experimental product, will be submitting an application for marketing approval to the FDA in December, and the FDA has designated the treatment as worthy of an expedited approval process.

"I'm telling patients when I see them that my hope is that patients will have access by late next summer, something like that," Vickery said. He added that although the study proved the treatment's effectiveness and safety only in children, adults would probably benefit in the same way.

How the study worked

To test the experimental therapy, 66 research centers in 10 countries recruited 551 participants who ranged in age from 4 to 55 and who all had a peanut allergy. Most -- 499 participants -- were between the ages of 4 and 17.

The treatment, which comes in powder-filled capsules, is an oral immunotherapy, and the concept is "treating an allergy by gradually exposing people to the very same thing they're allergic to," Vickery said. Essentially, the treatment is a peanut powder.

Ellis participated in the study at the Pediatric Clinical Research Unit at Arkansas Children's Hospital in Little Rock, which was overseen by Dr. Stacie M. Jones, a professor of pediatrics and chief of allergy and immunology at the University of Arkansas for Medical Sciences and Arkansas Children's Hospital.

"We were extremely well-informed about the entire process," Glover said. "You start at a super low dose and work your way up. You take it at the hospital under observation. Then, you take it at home every day. "

Three-quarters of the study participants were given the treatment in increasing amounts every two weeks until reaching maintenance, when they received the equivalent of one peanut daily. The remainder of the participants were given a placebo. At the conclusion of the study after a year, all of the participants faced an "exit food challenge": They ate, under a doctor's supervision, the equivalent of two peanuts.

Two-thirds of the treatment participants were able to tolerate this exit dose without a severe reaction. Half tolerated even twice that amount: a four-peanut dose.

Overall, participants experienced fewer side effects during the study than the researchers had anticipated. "It's intuitive that that process would trigger some allergic symptoms in many patients," Vickery said. A third completed the study with no more than mild side effects, such as stomachache.

Ellis experienced stomach cramps and vomiting multiple times during the study, usually on days when her dose was increased to raise her tolerance. "Having stomach cramps did not feel very good," she said. Still, she usually vomited, and the cramps passed quickly.

Once, she felt her throat constrict, and "it was harder for me to breathe," she said. She'd gone into anaphylaxis, a severe allergic reaction. The hospital staff reacted immediately and gave her a shot of epinephrine. "I felt safe with all the doctors and nurses around me. They can help you get through it," she said.

A little more than 11% of the children dropped out of the study due to severe side effects. Among children receiving the treatment, 10% required rescue epinephrine during the exit challenge, compared with 53% in the placebo group.

"These treatments really have the potential to transform people's lives," Vickery said, "and I have seen it happen firsthand: the sense of relief [families] get when a child becomes desensitized."

Trying to be 'bite safe'

Dr. Scott Sicherer, a professor of pediatrics and director of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai in New York, said the study is "the largest of the phase three studies in pharmaceutical-grade peanut."

"It's what a lot of families call trying to be 'bite safe.' it's not that you're curing the allergy; it's not that you're going to be able to eat peanut butter sandwiches," said Sicherer, who was not involved in the study. "It's really just to have a better threshold so that if you accidentally ate something that had a little bit of peanut in it, maybe you wouldn't have a reaction or the reaction wouldn't be so bad."

Though the immunotherapy treatment is simply a matter of gradually increasing your tolerance to peanuts, you could have a severe reaction at home. "This is not something to try at home," Sicherer said.

Aimmune has made peanut into a "pharmaceutical-grade" product, he said. "Most people think of it as medicinalized food." Doctors and patients both know exactly how much you're getting, he said, "and that's important because if you're reactive to, say, a 50th of a peanut, you don't want to have a mistake where you're suddenly getting a 10th of peanut."

Assuming the treatment wins FDA approval, Sicherer said, the conversation between doctors and patients will be, "Is it better to just avoid the food and ask a lot of questions at restaurants and be real careful, or do something like this and still don't eat the food and ask the questions in the restaurant, but at least know you have a bit of a safety valve?"

There are more than a few caveats when it comes to the treatment regimen. For one, it's "a commitment," he said. You cannot take a dose before exercising, and you can't skip doses, or you might have a severe reaction when you pick it up again.

Glover noted, "It's somewhat disruptive. You have to do it every day. Generally, we would take it after dinner." After giving the medicine, she added, parents must carefully monitor their children, preventing them from becoming too active or too hot.

Sicherer said, "The family that does this really, really, really has to be a rule follower. It's not easy." It would still be worth it to many, he said.

If this ends up being the first approved treatment, if it is covered by insurance and if details of whom it works for best were all worked out and the risks and benefits were clear, "that would be so amazing, because we haven't really had anything like that before," he said.

"It's not everything we would hope for, but it's still fantastic to be able to raise someone's threshold from a teeny tiny amount of peanut to a couple of peanuts or more," said Sicherer, who believes that other allergy products will be developed in time: "I can tell my patients that this might be the right thing for them, but if not, we're looking at things that might be easier and better down the road."

Glover acknowledges that "it's not a perfect solution. I would say it's been some work to go through this study, just in terms of a time commitment." Still, if it had taken twice the amount of time, she would have done it: "It's peace of mind."

Even though she dislikes the medicine's taste, Ellis also believes it is worth it. "It's definitely better," she would say to another kid with peanut allergy: "You know you can be around your friends when they have peanut butter on them."

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 75862

Reported Deaths: 3069
CountyConfirmedDeaths
Marion16088730
Lake7688278
Elkhart492685
Allen4002163
St. Joseph357883
Hamilton2829104
Vanderburgh202213
Hendricks1927108
Cass18029
Johnson1789119
Porter135539
Clark128749
Tippecanoe123811
Madison100665
LaPorte93130
Howard91365
Kosciusko86812
Bartholomew81747
Floyd80948
Marshall79323
Monroe76631
Delaware74552
Dubois70812
Vigo69911
Noble68829
Boone68746
Hancock68339
Jackson5965
Warrick58830
Shelby56527
LaGrange56310
Grant52930
Dearborn51228
Morgan49334
Clinton4444
Henry40620
Wayne38510
White37611
Montgomery35921
Lawrence35227
Harrison34823
Decatur34132
Putnam3128
Daviess27720
Miami2772
Scott27210
Jasper2552
Greene25434
Franklin24615
DeKalb2384
Gibson2314
Jennings22712
Steuben2133
Ripley2138
Carroll1962
Fayette1947
Perry18713
Posey1790
Starke1787
Wells1742
Orange17424
Fulton1722
Wabash1703
Jefferson1672
Knox1610
Whitley1556
Tipton14312
Washington1421
Sullivan1381
Spencer1373
Clay1245
Huntington1243
Randolph1244
Newton12010
Adams1092
Owen991
Jay920
Rush854
Pulaski811
Fountain742
Brown741
Blackford652
Ohio656
Benton640
Pike590
Vermillion580
Switzerland530
Parke511
Martin480
Crawford450
Union410
Warren241
Unassigned0206

Ohio Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 102826

Reported Deaths: 3708
CountyConfirmedDeaths
Franklin18697529
Cuyahoga13734505
Hamilton9766257
Lucas5448326
Montgomery443896
Summit3614223
Butler297663
Marion293545
Mahoning2595255
Pickaway239142
Stark1884140
Warren182139
Lorain181377
Columbiana167160
Trumbull1549108
Fairfield141632
Delaware134419
Licking131951
Clark117815
Lake113141
Wood106858
Clermont95311
Medina94535
Miami85839
Tuscarawas79314
Portage77163
Allen76946
Greene71812
Mercer63113
Belmont62326
Richland61412
Erie59728
Ashtabula57646
Geauga55944
Wayne54558
Ross4944
Darke40629
Huron4045
Madison40110
Ottawa39626
Sandusky39017
Hancock3893
Athens3602
Holmes3286
Lawrence3000
Auglaize2636
Union2601
Muskingum2431
Scioto2421
Jefferson2373
Seneca2283
Knox2127
Putnam21117
Shelby2104
Washington20922
Preble2072
Coshocton1967
Champaign1812
Morrow1762
Crawford1755
Hardin17012
Clinton1696
Highland1661
Logan1602
Ashland1543
Fulton1531
Wyandot1509
Defiance1504
Brown1462
Perry1403
Williams1363
Henry1222
Fayette1210
Guernsey1197
Hocking1189
Carroll1135
Monroe9418
Pike790
Jackson760
Van Wert732
Paulding700
Gallia701
Adams612
Meigs540
Vinton322
Morgan300
Harrison261
Noble160
Unassigned00
Fort Wayne
Clear
82° wxIcon
Hi: 83° Lo: 57°
Feels Like: 83°
Angola
Clear
79° wxIcon
Hi: 83° Lo: 57°
Feels Like: 79°
Huntington
Broken Clouds
81° wxIcon
Hi: 81° Lo: 58°
Feels Like: 82°
Decatur
Clear
79° wxIcon
Hi: 82° Lo: 57°
Feels Like: 81°
Van Wert
Clear
79° wxIcon
Hi: 82° Lo: 56°
Feels Like: 81°
Partly Sunny Wednesday
WFFT Radar
WFFT Temperatures
WFFT National

Community Events